Trial Details

Authorised
Basic Information
Clinical ID c5134
Identifier EUCTR2008-005015-17-NL
Trial Title Effect of N-acetylcysteine on thiopurine related hepatotoxicity in IBD patients - NACTOX
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions adult patients (18-70 years old) who have been treated with azathioprine, 6-mercaptopure or 6-thioguanine for inflammatory bowel disease, in whom hepatotoxicity occured as an adverse event, are eligible. Prior to definite inclusion, the patients will be s
Interventions Trade Name: acetylcysteineProduct Name: acetylcysteinePharmaceutical Form: Effervescent tabletINN or Proposed INN: ACETYLCYSTEINECAS Number: 616911Concentration unit: mg milligram(s)Concentration type: equalConcentration nu
Participant Information
Sponsor VU university medical centre
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL